Circulating Tumour DNA as a Potential Cost-Effective Biomarker to Reduce Adjuvant Chemotherapy Overtreatment in Stage II Colorectal Cancer
Yat Hang To, Koen Degeling, Suzanne Kosmider, Rachel Wong, Margaret Lee, Catherine Dunn, Grace Gard, Azim Jalali, Vanessa Wong, Maarten J. IJzerman, Peter Gibbs, Jeanne Tie
Topics & Concepts
MedicineColorectal cancerInternal medicineOncologyConfidence intervalCohortCancerProspective cohort studyQuality-adjusted life yearQuality of Life ResearchStage (stratigraphy)Cost effectivenessPublic healthPathologyRisk analysis (engineering)BiologyPaleontologyCancer Genomics and DiagnosticsGenetic factors in colorectal cancerColorectal Cancer Screening and Detection